MedTrace Logo

Maintenance Chemotherapy in Metastatic Breast Cancer

NCT00289263 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 524

Last updated 2006-02-09

No results posted yet for this study

Summary

This is a randomized, prospective and multicenter phase III study. Two-hundred-sixty-two (262) patients on each arm will be recruited in the study.

Conditions

Interventions

DRUG

Paclitaxel

Sponsors & Collaborators

Principal Investigators

  • PierFranco Conte, MD · University of Modena, Italy

  • Dino Amadori, MD · Morgagni-Pierantoni Hospital, Forli, Italy

  • Mario Delena, MD · Oncology Institute, Bari, Italy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-04-30
Completion
2003-10-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00289263 on ClinicalTrials.gov